⌘K

venBio Partners logo

venBio Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Equity

Attovia Therapeutics logo
Attovia Therapeutics

Biopharma • Immune-mediated diseases

Deep Track Capital logo
Vida Ventures logo
Sanofi Ventures logo
Mirae Asset Capital Life Science logo

Attovia Therapeutics is a biopharmaceutical company developing treatments for immune-mediated diseases using its proprietary ATTOBODY platform.

Series C
$90M
04/16/2025
Article
Axonis Therapeutics logo
Axonis Therapeutics

Biotechnology • Neuromedicines

venBio Partners logo
Sofinnova Investments logo
Solasta Ventures logo
SCI Ventures logo

Axonis Therapeutics is a biotechnology company developing novel neuromedicines targeting neurological disorders like epilepsy and pain.

Series A
$115M
10/30/2024
Article
Vicebio logo
Vicebio

Biopharmaceutical • Vaccines

TCGX logo
venBio logo
UniQuest logo
Medicxi logo

Vicebio Ltd is a biopharmaceutical company developing next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology.

Series B
$100M
09/23/2024
Article
Candid Therapeutics logo
Candid Therapeutics

Biotechnology • Autoimmune therapies

Venrock Healthcare Capital Partners logo
Vida Ventures logo
TCGX logo
Third Rock Ventures logo

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Equity
$370M
09/09/2024
Article